fbpx

Psychedelic Medicine

Association

Psychedelic Medicine

Association

Psychedelic Medicine for the Veteran Community: Healing the Invisible Wounds of War

Log in to Watch the Recording.

*Exclusive for members.

Thursday, October 28th at 5 pm Pacific, 8 pm Eastern >> Watch the recording now >>

Join Us For an EXCLUSIVE Panel Discussion for Members of The Psychedelic Medicine Association:

Psychedelic Medicine for the Veteran Community: Healing the Invisible Wounds of War

Panel Moderator:

Lynn Marie Morski, MD, ESQ

President - Psychedelic Medicine Association

Panelists:

Kate Pate, PhD

CEO & Founder of Coruna Medical, LLC Board Member, Psychedelic Medicine Association

Dr. Kate Pate is a neurophysiologist, athlete, entrepreneur, and coach dedicated to helping struggling service members, veterans, and first responders. She advocates for and educates on functional and non-traditional approaches to mental, physical, and spiritual health. Kate is a Board Member of the Psychedelic Medicine Association, and she was the Director of Research for Heroic Hearts Project but recently stepped down to free up more time for her role as an official integration coach for the organization. In addition to coaching, Kate is also the CEO & Founder of Coruna Medical, LLC, a military-specific medical device company focused on solving the difficult problems facing the injured warfighter, especially as these problems pertain to administering medical care in austere environments. Kate comes from a military family and has always been passionate about finding ways to help those who serve others. Her primary objectives are to help people find the path to healing that works best for them, to change the narrative around how we discuss psychedelics and health in our communities, and ultimately, to remove the stigmas associated with psychedelic use, mental health diagnoses, and asking for help.

Marcus and Amber Capone

Founders of VETS, Inc.

Marcus and Amber Capone have a 20+ year history of never giving up on one another. After meeting at Southern Illinois University in 1997 and marrying three years later, the young couple moved to Coronado, CA where Marcus began training to become a U.S. Navy SEAL, graduating with BUD/S class 236 just one month after the attacks of 9/11.
Like many military families, the Capones adapted to the high operational tempo of combat deployments and wartime training cycles, sometimes keeping Marcus away from home for up to 300 days per year. After 13 years and 7 tours, it was the transition away from the SEAL teams that would prove to be the greatest challenge yet.


After years of escalating hardships, misdiagnoses, and failed avenues of healing, Amber was able to arrange for Marcus to leave the U.S. in 2017 to undergo a plant medicine experience; an intervention the couple attributes to saving his life as well as their family. Marcus immediately felt a deep conviction to pay this healing forward to his former teammates, which subsequently launched a successful grassroots effort that culminated in the official formation of VETS in 2019.


As a 501(c)(3) organization, VETS provides resources, research, and advocacy for U.S. veterans seeking healing through psychedelic-assisted therapy alternatives. To date, VETS has raised funding for over 400 Special Operations veterans to receive this critical lifeline. Marcus and Amber are committed to fighting for veterans and their families just as hard as they’ve fought for their own, with an ultimate goal of making these therapies available within the borders of the United States for all who need them.

Jesse Gould

President/Founder Heroic Hearts Project

Jesse Gould is a pioneer in psychedelic therapies. As Founder and President of the Heroic Hearts Project, he has spearheaded the research and acceptance of ayahuasca, ibogaine, ketamine, and psilocybin therapy programs for military veterans. Jesse has connected countless veterans to psychedelic treatments, partnered with the world’s leading psychedelic centers, and is researching psychiatric applications with the University of Colorado Boulder, the University of Georgia, University of Texas, Austin, and Imperial College of London. His mission is to help military veterans struggling with mental trauma and spread awareness of the benefits that psychedelic therapies offer as an alternative treatment to pharmaceuticals. Jesse has spoken globally about the benefits of psychedelics on mental health and has been featured in the New York Times and recognized as one of the most influential voices in psychedelics today.

Service members who have experienced combat, deployments, and intense training exercises often have a unique set of both mental and physical conditions stemming from their time in the military, and for which modern medicine has struggled to find solutions.

However, psychedelics such as ayahuasca, ibogaine, and 5-MeO-DMT, among others, are showing great promise for some of the conditions often faced by veterans, including PTSD and TBI.

As November is National Veteran and Military Families Month, we wanted to take a look at how these psychedelic medicines have been making an impact for many of our former servicemen and women and hear from those whose lives were so impacted that they made it their mission to help other veterans receive the same healing.

To answer those questions, we were honored to have panelists on this month’s webinar to cover:

  • What types of physical and mental conditions are most commonly seen in the veteran population
  • How psychedelic medicines address some of these conditions
  • What else, besides the psychedelic therapeutics themselves, is necessary to support healing
  • How nonprofit organizations are helping veterans afford psychedelic therapies

…and much more!

As always, there is ample time for audience Q & A, so you’ll get to interact with the panelists directly!

Panel discussion took place on Thursday, November 18th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so.

You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.